CLASS II Drug recall · Reported 9 Sep 2020 · FDA Enforcement Report

HGH Vitality Homeopathic recalled by Grato Holdings

Grato Holdings is recalling HGH Vitality Homeopathic, distributed in Utah. The recall was initiated on 16 Jul 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot P2613
Quantity recalled850 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1558-2020
FDA event ID
86233
Recalling firm
Grato Holdings, Woodbine, IA
Classification
Class II
Status
Terminated
Recall initiated
16 Jul 2020
FDA classified
29 Aug 2020
Reported
9 Sep 2020
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

16 Jul 2020Recall initiated by company
29 Aug 2020Classified by FDA+44 days
9 Sep 2020Published in enforcement report+11 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Error on Declared Strength

Product as listed by the FDA

HGH Vitality Homeopathic, 90 tablets, NDC 43742-1299-1, Dist. by Deseret Biologicals, Inc. 469 W. Parkland Drive, Sandy, UT 84070, NDC: 43742-1299-1

Where it was distributed

One direct account in UT

Utah

Questions about this recall

Is HGH Vitality Homeopathic recalled?

Yes. Grato Holdings recalled HGH Vitality Homeopathic on 16 Jul 2020. The recall is Class II and its status is Terminated. Recall number D-1558-2020.

Why was it recalled?

Labeling: Error on Declared Strength

Which lots are affected?

Lot P2613

Where was it sold?

One direct account in UT

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Grato Holdings

All 18